OLVIG
TMCI icon

Oliver Lagore Vanvalin Investment Group’s Treace Medical Concepts TMCI Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,000
Closed -$6.65K – 763
2024
Q2 		$6.65K Buy
+1,000
New +$8.08K ﹤0.01% 462

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's TMCI Position: Q3 2024 in Review

Oliver Lagore Vanvalin Investment Group sold out of Treace Medical Concepts (TMCI) in Q3 2024, closing a stake of 1,000 shares — an estimated $6.65K sold.

Oliver Lagore Vanvalin Investment Group first reported a position in TMCI in Q2 2024 and held it in 1 quarter. The position peaked at $6.65K in Q2 2024. 134 funds tracked by Wall St. Rank hold TMCI as of Q3 2024.

  • Oliver Lagore Vanvalin Investment Group reported no remaining Treace Medical Concepts position as of Q3 2024 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 1,000 Treace Medical Concepts shares in Q3 2024, an estimated $6.65K.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Treace Medical Concepts in Q2 2024 and held it in 1 quarter.
  • Oliver Lagore Vanvalin Investment Group's Treace Medical Concepts position peaked at $6.65K in Q2 2024.
  • 134 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q3 2024, filed 4 Nov 2024.